Findings expand Telomir-1’s oncology profile into cancers of the blood, adding to previously reported activity in triple-negative breast, pancreatic, and aggressive prostate cancer models. MIAMI, FL / ...
Two North Carolina sisters in their 20s, part of a set of triplets, were diagnosed with breast cancer within months of each ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback